Eascra Biotech is at the forefront of nanomedicine, specializing in the development of innovative therapeutic delivery systems designed to target challenging tissues such as articular cartilage, kidneys, and solid tumors rich in extracellular matrix. Their proprietary Janus base nanoparticles (JBNps) represent a significant advancement in drug delivery technology. These DNA-inspired synthetic molecules are capable of encapsulating various therapeutic agents, including siRNA, mRNA, proteins, and peptides, while ensuring stability at room temperature and preserving bioactivity over extended periods. This technology aims to enhance treatment efficacy for conditions like osteoarthritis and facilitate direct therapeutic delivery to solid tumors, thereby minimizing systemic exposure and reducing side effects for patients.

In addition to JBNps, Eascra Biotech offers a range of products that further exemplify their commitment to advancing therapeutic applications. The JBNp™ platform is specifically designed for mRNA therapeutics and gene editing, effectively overcoming barriers to tissue infiltration. Furthermore, the JBNm™ product serves as a cell-free injectable scaffold aimed at cartilage repair and regeneration in orthopedic applications. Complementing these offerings, the JBNm-Tissue Chip™ provides a microchip simulation of knee joints, which accelerates biomedical research and drug testing processes. Collectively, these technologies position Eascra Biotech as a leader in the development of precision therapeutics for complex medical challenges.

United States

Based on DNA nanotechnology, our novel family of Janus base nanomaterials provides highly effective, super biocompatible solutions that enable enhanced therapeutic delivery and regenerative medicine for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Our three generations of DNA-inspired nanotubes are a cost-effective alternative to existing options, and they have excellent scalability. We can customize our Janus base nanotechnologies to enhance the therapeutic efficacy of drug treatments for a variety of chronic conditions and medical needs.

Eascra Biotech

Company Details